Breaking Down Zhejiang Yongtai Technology Co.,Ltd. Financial Health: Key Insights for Investors

Zhejiang Yongtai Technology's latest numbers paint a complex picture for investors: revenue for the nine months to Sept 30, 2025 rose to CNY 4,028.35 million (≈+20.6% year-on-year) even as the company reported a H1 2025 net profit attributable to shareholders of RMB 56.625-64.175 million (a +50.40% to +70.45% jump from RMB 37.6503 million in H1 2024), while nine-month results show a narrow net profit margin of 3.11% versus a net loss margin of 6.74% a year earlier; yet material headwinds remain - a reported net loss of CNY 478 million with diluted EPS of CNY -0.52, total assets of CNY 11.04 billion against liabilities of CNY 8.12 billion (debt-to-equity ~2.78), cash and short-term investments down to CNY 469.76 million (‑48.59% YoY) even as Q2 operating cash flow surged to CNY 239.98 million (+803.58% YoY) - factor in a market cap of CNY 16.82 billion (share price CNY 17.88) and a P/B of 5.69 alongside an ROE of -13.46% and EPS growth of -53.10%, and you have a mix of growth, leverage and liquidity dynamics that demand a closer look - read on for a line-by-line breakdown of revenue drivers, profitability metrics, balance-sheet leverage, cash-flow swings, valuation and the key risks and opportunities shaping investor decisions.

Zhejiang Yongtai Technology Co.,Ltd. (002326.SZ) - Revenue Analysis

Zhejiang Yongtai Technology's top-line performance through 2025 shows recovery but continued volatility across core segments (crop-science, pharmaceuticals, lithium-battery materials). Key figures and drivers are summarized below.

• Revenue growth for 9M2025: CNY 4,028.35 million vs. CNY 3,338.76 million (≈ +20.6%).
• H1 2025 net profit attributable to shareholders: CNY 56.625-64.175 million (YoY +50.40% to +70.45% vs. CNY 37.6503 million in H1 2024).
• Fiscal year growth pattern: +21.21% (FY ending Sep 2025) after a -34.70% decline the prior year - signaling revenue volatility.

Primary operational contributors to the 2025 revenue uplift:

• Increased production capacity and higher utilization at Inner Mongolia Yongtai, Yongtai New Energy, and Yongtai High‑Tech.
• Higher production and sales volumes in crop‑science and lithium‑battery segments driven by capacity expansion.
• Cross‑segment synergies as new energy output scales, supporting consolidated revenue growth.

Key headwinds and margin drivers:

• Despite revenue growth, the company has not yet achieved sustainable overall profitability due to low market prices for lithium battery materials and price declines for certain pharmaceutical products after patent expirations.
• Segment price pressure (lithium materials) compresses gross margins even as volumes rise.
• Revenue inconsistency (sharp prior-year decline then rebound) increases forecasting risk for investors.

Selected numerical snapshot for investor reference:

For additional context on corporate direction and commitments, see: Mission Statement, Vision, & Core Values (2026) of Zhejiang Yongtai Technology Co.,Ltd.

Zhejiang Yongtai Technology Co.,Ltd. (002326.SZ) - Profitability Metrics

• H1 2025 net profit attributable: RMB 56.625M-64.175M (YoY +50.40% to +70.45%).
• Nine-month net profit margin (to 2025-09-30): 3.11% (prior: -6.74%).
• Reported net loss for the period: CNY 478M; diluted EPS: CNY -0.52.
• Return on equity (ROE): -13.46%.
• EPS growth rate: -53.10% year-over-year.

Zhejiang Yongtai Technology Co.,Ltd. (002326.SZ) - Debt vs. Equity Structure

• High leverage: A debt-to-equity ratio of ~2.78 implies liabilities are roughly 2.8x shareholder equity, increasing financial risk and sensitivity to interest rate and earnings volatility.
• Gradual liability growth: Total liabilities rose by 1.65% YoY, a repeated sign of incremental debt accumulation across reporting periods.
• Static equity base: Total equity unchanged YoY suggests limited new equity issuance or retained-earnings growth during the period, placing the onus of funding on liabilities.

Zhejiang Yongtai Technology Co.,Ltd. (002326.SZ) - Liquidity and Solvency

Key cash and flow metrics for Zhejiang Yongtai Technology Co.,Ltd. reveal mixed liquidity dynamics: a sharp decline in cash reserves alongside a pronounced recovery in operating cash generation, while investment and financing activities produced material outflows in 3Q 2025.

• Cash & short-term investments (as of 2025-06-30): CNY 469.76 million (down 48.59% YoY).
• Net cash flow from operating activities (Q2 2025): CNY 239.98 million (up 803.58% YoY).
• Net cash flow from investing activities (Q3 2025): -CNY 365.52 million (substantial outflow).
• Net cash flow from financing activities (Q3 2025): -CNY 61.28 million (outflow).

Implications for short-term liquidity and solvency include the need to reconcile lower cash reserves with stronger operating cash generation and sizable investment outlays. For further investor context and ownership trends, see: Exploring Zhejiang Yongtai Technology Co.,Ltd. Investor Profile: Who's Buying and Why?

Zhejiang Yongtai Technology Co.,Ltd. (002326.SZ) - Valuation Analysis

Key valuation and profitability metrics for Zhejiang Yongtai Technology Co.,Ltd. as of November 17, 2025 highlight a company transitioning from loss to modest profitability but still trading at a premium versus book value and delivering negative shareholder returns on equity.

• Valuation premium: P/B of 5.69 implies high market expectations relative to book equity - investors are pricing future growth or intangible value.
• Profit recovery: Net margin moved to +3.11% in 9M 2025 from a -6.74% loss margin a year earlier, indicating operational improvement and path toward sustained profitability.
• Shareholder returns: ROE at -13.46% signals that, despite margin improvement, equity holders have yet to receive positive returns; capital efficiency remains a concern.
• Earnings volatility: EPS decline of -53.10% shows pronounced near-term earnings pressure or one-off impacts affecting comparability.

• Implication for valuation multiples: A high P/B alongside negative ROE and steep EPS decline suggests the market is forward-looking but also that downside risk exists if margins or earnings do not continue to recover.
• Investor focus areas: revenue growth sustainability, margin expansion drivers (cost control, product mix), balance sheet strength versus goodwill/intangible assets backing book value.

For deeper investor-focused context and shareholder composition, see: Exploring Zhejiang Yongtai Technology Co.,Ltd. Investor Profile: Who's Buying and Why?

Zhejiang Yongtai Technology Co.,Ltd. (002326.SZ) - Risk Factors

• Market-price pressure: Low market prices for lithium battery materials have compressed gross margins on the company's core chemical/materials businesses, making consistent profitability more difficult to achieve.
• Pharmaceutical product declines: Several pharma products have seen price erosion following patent expirations, reducing revenue visibility and contribution from higher-margin drugs.
• High leverage: A debt-to-equity ratio of approximately 2.78 signals substantial financial leverage, elevating refinancing, interest-rate and solvency risk if cash flows weaken.
• Poor shareholder returns: Return on equity (ROE) stands at -13.46%, indicating the company is currently destroying equity rather than generating positive returns for investors.
• Earnings deterioration: Earnings per share (EPS) growth is negative at -53.10% year-over-year, reflecting a sizeable decline in per-share profitability.
• Profitability trend: For the nine months ended September 30, 2025, net profit margin improved to 3.11% from a net loss margin of -6.74% in the same period a year earlier-showing recovery but still thin margins.

• Liquidity and interest risk: With high leverage, the company is vulnerable to rising interest costs and tighter credit conditions; operating setbacks could force asset sales or equity raises at unfavorable terms.
• Revenue concentration risk: Dependence on cyclical lithium-material markets and a shrinking portfolio of protected pharma products increases earnings volatility.
• Execution risk: Restoring sustainable profitability depends on successful cost controls, product portfolio adjustments, and stabilizing end-market prices.

For broader corporate context and background on strategy and ownership, see Zhejiang Yongtai Technology Co.,Ltd.: History, Ownership, Mission, How It Works & Makes Money

Zhejiang Yongtai Technology Co.,Ltd. (002326.SZ) - Growth Opportunities

• Crop science: Inner Mongolia Yongtai has launched several crop science product projects; production capacity is being brought online gradually, supporting revenue ramp in this segment.
• Lithium battery materials: Entry into specialty battery-materials markets targets fast-growing demand from EVs and energy storage, offering higher-margin diversification.
• Pharmaceutical intermediates: Expansion into pharma intermediates leverages existing chemical synthesis capabilities to capture specialty-chemicals pricing and contract opportunities.
• Operational programs: Company-wide initiatives on cost reduction and efficiency improvement (procurement optimization, process yields, energy use) aim to lift EBITDA margins and cash flow conversion.

• Investor signal: A P/B of 5.69 and market cap ~CNY 16.82bn reflect investor expectations for above-average growth tied to new product ramps and higher-margin specialty segments.
• Profitability trajectory: Improvement from a -6.74% net margin (9M 2024) to +3.11% (9M 2025) shows operational recovery and validates cost/efficiency measures.
• Execution risks: Timelines for capacity release at Inner Mongolia Yongtai, commercialization success in lithium and pharma segments, and commodity-price exposure remain key near-term variables.